Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Using Failure Mode, Effect and Criticality Analysis to improve safety in the cancer treatment prescription and administration process.

Buja A, De Luca G, Ottolitri K, et al. Using failure mode, effect and criticality analysis to improve safety in the cancer treatment prescription and administration process. J Pharm Policy Pract. 2023;16(1):9. 10.1186/s40545-023-00512-9

Save
Print
March 8, 2023
Buja A, De Luca G, Ottolitri K, et al. J Pharm Policy Pract. 2023;16(1):9.
View more articles from the same authors.

Failure Mode, Effect and Criticality Analysis (FMECA) is a prospective method for identifying and preventing potential error risks. Using FMECA, public health medical residents calculated a Risk Priority Number (RPN), or criticality, for each possible failure mode in cancer treatment prescription and administration. Each phase of the cancer treatment process had at least one critical step identified, and actions were developed to reduce the likelihood of the error occurring and/or to increase the likelihood of the error being detected.

Save
Print
Cite
Citation

Buja A, De Luca G, Ottolitri K, et al. Using failure mode, effect and criticality analysis to improve safety in the cancer treatment prescription and administration process. J Pharm Policy Pract. 2023;16(1):9. 10.1186/s40545-023-00512-9

Related Resources From the Same Author(s)
Related Resources